Award
National Institute of Arthritis and Musculoskeletal and Skin Diseases 1R01AR085258-01A1
Circulating cell free tumor DNA (ctDNA) in patients with immune checkpoint inhibitor associated inflammatory arthritis (ICI-IA): developing a biomarker to assess immunosuppressive drug safety
Recipient
Hospital for Special Surgery
Award Amount
$267,423.00
Ceiling
$267,423.00
Awarded
September 08, 2025
Identifier
1R01AR085258-01A1
NIH grant awarded to Hospital for Special Surgery to develop a biomarker using circulating tumor DNA to assess immunosuppressive drug safety in patients with immune checkpoint inhibitor associated inflammatory arthritis.
Description
This NIH-funded project aims to develop a biomarker for early detection of cancer recurrence in patients with ICI-IA, utilizing advanced genomic and deep learning techniques to improve patient outcomes.